Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exits

Reuters2026/09/01 10:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Valion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s departure.
Board added Jared Malbin, COO of Lucid Capital Markets with broker-dealer operations, compliance, finance, capital-markets experience.
Thomas Jensen joined as director; he is CEO, co-founder, director of Allarity Therapeutics with biotech and oncology leadership experience.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006848), on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exits

You may also like

Crypto prices